NCT02832843 is a clinical trial in Mycobacterium Infections, Nontuberculous, sponsored by Seoul National University Hospital.

Who is sponsoring NCT02832843?

NCT02832843 is sponsored by Seoul National University Hospital.

What condition does NCT02832843 study?

NCT02832843 studies Mycobacterium Infections, Nontuberculous.

Is NCT02832843 still recruiting?

NCT02832843 is currently completed. Last updated 13 December 2019.

Last reviewed 2019-12-13 · How we verify

NCT02832843

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Genome-Wide Association Study in Patients With Nontuberculous Mycobacterial Lung Disease

Completed Last updated 13 December 2019

What this trial tests

trial in Mycobacterium Infections, Nontuberculous in 2,808 participants. Completed in 3 October 2019.

Timeline

11 July 2016

Primary endpoint
20 November 2017

3 October 2019

Quick facts

Lead sponsor	Seoul National University Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	2,808
Start date	11 July 2016
Primary completion	20 November 2017
Estimated completion	3 October 2019
Sites	1 location across South Korea

Conditions studied

Mycobacterium Infections, Nontuberculous — all drugs for Mycobacterium Infections, Nontuberculous →

Sponsor

Seoul National University Hospital

Who can join

Adults 18 to 75, any sex, with Mycobacterium Infections, Nontuberculous. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study was to elucidate genetic susceptibility of patients with nontuberculous mycobacterial lung disease using genome-wide association study.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Clinical Trials involving <i>Mycobacterium abscessus</i>: An update.
Moore JE, Millar BC. · · 2025 · PMID 40313987

Verify or expand the search:

Other Seoul National University Hospital trials

Trials by the same sponsor.

NCT07262944 — EOI Block in Otoplasty With Rib Cartilage Graft · NA · recruiting
NCT07464210 — Nemtabrutinib, Bortezomib, and Rituximab for WM · Phase 2 · not yet recruiting
NCT07550803 — Effect of Intraoperative Dexamethasone on Early Postoperative Sleep Quality in Patients Undergoing Nasal Surgery · NA · not yet recruiting
NCT07522138 — Home-based Self-exercise in Patients With Parkinson's Disease: A Feasibility Study · NA · not yet recruiting
NCT07476651 — Scout Dose of Resin Microspheres · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02832843 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Seoul National University Hospital
Last refreshed: 13 December 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02832843.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing